Literature DB >> 15862480

Health related quality of life of patients with refractory angina before and one year after enrolment onto a refractory angina program.

R K Moore1, D Groves, S Bateson, P Barlow, C Hammond, A A Leach, M R Chester.   

Abstract

OBJECTIVE: This study was designed to assess the impact of a refractory angina programme on the health related quality of life for patients with chronic refractory angina (CRA) one year following enrolment.
DESIGN: A one year prospective audit.
SETTING: Specialist refractory angina clinic at a tertiary cardiac referral centre. PATIENTS: 69 consecutive refractory angina patients referred to a regional refractory angina centre from 1/03/2001 to 1/09/2002.
INTERVENTIONS: Pain treatment algorithm in accordance with the recommendations of the national refractory angina guideline committee. MAIN OUTCOME MEASURES: Improvements in quality of life indices were assessed using Seattle angina questionnaire (SAQ), and short form-12 (SF-12) with changes in mood determined using the hospital anxiety and depression (HAD) questionnaire.
RESULTS: All dimensions of the SF-12 and SAQ were superior at one year with significant improvement seen with the mental component of SF-12 (p = 0.023), and four of the five SAQ domains, angina stability (p = 0.028), angina frequency (p=0.02), treatment satisfaction (p=0.001) and quality of life (p < 0.001). All the significant changes within the SAQ domains were large enough to be considered clinically relevant. At one year the anxiety and depression domains were significantly improved from baseline (p = 0.015, 0.018) with clinical anxiety levels falling significantly from 55% to 40%, a relative reduction of 28% (p = 0.008).
CONCLUSIONS: Implementation of the national refractory angina guidelines in a prospective study of 69 consecutive CRA patients significantly improved health related quality of life status at one year.

Entities:  

Mesh:

Year:  2005        PMID: 15862480     DOI: 10.1016/j.ejpain.2004.07.013

Source DB:  PubMed          Journal:  Eur J Pain        ISSN: 1090-3801            Impact factor:   3.931


  11 in total

1.  Alternative treatments for angina.

Authors:  Michael R Chester; John D Bridson
Journal:  Heart       Date:  2007-08       Impact factor: 5.994

Review 2.  An overview of treatment approaches for chronic pain management.

Authors:  Nicholas Hylands-White; Rui V Duarte; Jon H Raphael
Journal:  Rheumatol Int       Date:  2016-04-23       Impact factor: 2.631

3.  Myocardial ischaemia and cardiac pain - a mysterious relationship.

Authors:  Austin Leach; Mike Fisher
Journal:  Br J Pain       Date:  2013-02

Review 4.  Management of Refractory Angina Pectoris.

Authors:  Kevin Cheng; Paul Sainsbury; Michael Fisher; Ranil de Silva
Journal:  Eur Cardiol       Date:  2016-12

5.  Symptom clusters and health-related quality of life in people with chronic stable angina.

Authors:  Laura P Kimble; Sandra B Dunbar; William S Weintraub; Deborah B McGuire; Sharon F Manzo; Ora L Strickland
Journal:  J Adv Nurs       Date:  2011-02-24       Impact factor: 3.187

Review 6.  Treatment of refractory angina in patients not suitable for revascularization.

Authors:  Timothy D Henry; Daniel Satran; E Marc Jolicoeur
Journal:  Nat Rev Cardiol       Date:  2013-12-24       Impact factor: 32.419

7.  Safer cardiac surgery.

Authors:  Alan F Merry
Journal:  J Extra Corpor Technol       Date:  2009-12

8.  A hybrid cardiac rehabilitation is as effective as a hospital-based program in reducing chest pain intensity and discomfort.

Authors:  Mozhgan Saeidi; Ali Soroush; Saeid Komasi; Puneetpal Singh
Journal:  Korean J Pain       Date:  2017-09-29

9.  Conversion of the Seattle Angina Questionnaire into EQ-5D utilities for ischemic heart disease: a systematic review and catalog of the literature.

Authors:  Harindra C Wijeysundera; Sara Farshchi-Zarabi; William Witteman; Maria C Bennell
Journal:  Clinicoecon Outcomes Res       Date:  2014-05-19

10.  Angina self-management plan and quality of life, anxiety and depression in post coronary angioplasty patients.

Authors:  Marzieh Moattari; Fakhteh Adib; Javad Kojuri; Seyed Hamid Reza Tabatabaee
Journal:  Iran Red Crescent Med J       Date:  2014-11-09       Impact factor: 0.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.